213 related articles for article (PubMed ID: 191877)
1. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.
Tateson JE; Moncada S; Vane JR
Prostaglandins; 1977 Mar; 13(3):389-97. PubMed ID: 191877
[TBL] [Abstract][Full Text] [Related]
2. Modulation of human platelet adenylate cyclase by prostacyclin (PGX).
Gorman RR; Bunting S; Miller OV
Prostaglandins; 1977 Mar; 13(3):377-88. PubMed ID: 191876
[TBL] [Abstract][Full Text] [Related]
3. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
Vargaftig BB; Chignard M
Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
5. Inhibition of platelet aggregation by 6-keto-PGE1; lack of an effect on cyclic GMP levels.
Pontecorvo EG; Myers CB; Lippton HL; Kadowitz PJ
Prostaglandins Med; 1981 May; 6(5):473-83. PubMed ID: 6267636
[TBL] [Abstract][Full Text] [Related]
6. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
Miller OV; Gorman RR
J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
[TBL] [Abstract][Full Text] [Related]
7. Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets.
Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Antonaccio MJ; Fried J
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):387-99. PubMed ID: 6275567
[No Abstract] [Full Text] [Related]
8. Cyclic AMP and platelet prostaglandin synthesis.
Gerrard JM; Peller JD; Krick TP; White JG
Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.
Miller OV; Johnson RA; Gorman RR
Prostaglandins; 1977 Apr; 13(4):599-609. PubMed ID: 193153
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
[TBL] [Abstract][Full Text] [Related]
11. Refractoriness of diabetic platelets to inhibitory prostaglandins.
Lagarde M; Berciaud P; Burtin M; Dechavanne M
Prostaglandins Med; 1981 Oct; 7(4):341-7. PubMed ID: 6273957
[TBL] [Abstract][Full Text] [Related]
12. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
13. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotides in platelet function.
Haslam RJ; Davidson MM; Fox JE; Lynham JA
Thromb Haemost; 1978 Oct; 40(2):232-40. PubMed ID: 216130
[TBL] [Abstract][Full Text] [Related]
15. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of different arachidonic acid metabolites on cyclic nucleotide accumulation in human peripheral lymphocytes.
Lanefelt F; Martinsson A; Hjemdahl P; Fredholm BB
Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):336-44. PubMed ID: 6295066
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
19. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
Malmsten C; Granström E; Samuelsson B
Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
